Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Blueprint Medicines Corp.
DescriptionRET-specific kinase inhibitor
Molecular Target Ret proto-oncogene (RET)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today